Gastrointestinal Cancer News

The FDA granted priority review to ripretinib for treatment of advanced gastrointestinal stromal tumors, according to a press release from the agent’s manufacturer.

Patients with myocarditis related to immune checkpoint inhibitors and either a preserved or reduced ejection fraction had a reduced global longitudinal strain, according to a study published in the Journal of the American College of Cardiology.

Bleeding in the lower gastrointestinal tract increased risk for incident colorectal cancer in patients with atrial fibrillation who were treated with oral anticoagulants, according to a study published in the European Heart Journal.

ASCO has named the refinement of surgical treatment of cancer as the Advance of the Year, recognizing emerging novel systemic therapies that changed the role of cancer surgery.

A steep increase in incidence of colorectal cancer among patients aged between 49 and 50 years may suggest that many cases go undetected in younger patients before they reach routine, average-risk screening at age 50 years, according to data published in JAMA Network Open.

Treatment to eradicate Helicobacter pylori infection decreased the risk for gastric cancer among first-degree relatives of individuals with the malignancy, according to results of a randomized study published in The New England Journal of Medicine.

Fusobacterium nucleatum may be partially responsible for the sharp increase in colorectal cancer incidence among individuals aged younger than 45 years, according to preliminary results of an ongoing study presented at Gastrointestinal Cancers Symposium.

An investigational blood-based assay demonstrated efficacy in detecting multiple types of cancer, including gastrointestinal cancers, at various stages, according to study results presented at Gastrointestinal Cancers Symposium.

Click here to read the Cover Story, “Oncologists must be ‘very cautious’ as liquid biopsy use expands.”

So-called “liquid biopsies” — noninvasive tests used to evaluate blood for cancer cells or DNA — have been refined extensively over the past decade, leading to a growing number of applications in cancer treatment.